 | • レポートコード：GIR-105X13237 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、パンデミックインフルエンザワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。パンデミックインフルエンザワクチンの種類別市場規模（インフルエンザA（H1N1）ワクチン、その他）、用途別市場規模（成人、小児）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・パンデミックインフルエンザワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、GlaxoSmithKline、Novartis、Sanofi、Valneva、Lupin、Chiron Panacea、Solvay and Serum Institute of India Pvt. Ltd.、Sementis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インフルエンザA（H1N1）ワクチン、その他 ・用途別分析2016年-2026年：成人、小児 ・パンデミックインフルエンザワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・パンデミックインフルエンザワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・パンデミックインフルエンザワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・パンデミックインフルエンザワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・パンデミックインフルエンザワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pandemic Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pandemic Influenza Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pandemic Influenza Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pandemic Influenza Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Influenza A (H1N1) Vaccines
Other
Market segment by Application can be divided into
Adult
Paediatric
The key market players for global Pandemic Influenza Vaccine market are listed below:
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Valneva
Lupin
Chiron Panacea
Solvay and Serum Institute of India Pvt. Ltd.
Sementis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Pandemic Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pandemic Influenza Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Influenza A (H1N1) Vaccines
1.2.3 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Pandemic Influenza Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Paediatric
1.4 Global Pandemic Influenza Vaccine Market Size & Forecast
1.4.1 Global Pandemic Influenza Vaccine Sales in Value (2016-2026))
1.4.2 Global Pandemic Influenza Vaccine Sales in Volume (2016-2026)
1.4.3 Global Pandemic Influenza Vaccine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Pandemic Influenza Vaccine Production Capacity Analysis
1.5.1 Global Pandemic Influenza Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Pandemic Influenza Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pandemic Influenza Vaccine Market Drivers
1.6.2 Pandemic Influenza Vaccine Market Restraints
1.6.3 Pandemic Influenza Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Pandemic Influenza Vaccine Product and Services
2.1.4 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Product and Services
2.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Pandemic Influenza Vaccine Product and Services
2.3.4 Novartis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Pandemic Influenza Vaccine Product and Services
2.4.4 Sanofi Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Valneva
2.5.1 Valneva Details
2.5.2 Valneva Major Business
2.5.3 Valneva Pandemic Influenza Vaccine Product and Services
2.5.4 Valneva Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Pandemic Influenza Vaccine Product and Services
2.6.4 Lupin Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Chiron Panacea
2.7.1 Chiron Panacea Details
2.7.2 Chiron Panacea Major Business
2.7.3 Chiron Panacea Pandemic Influenza Vaccine Product and Services
2.7.4 Chiron Panacea Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Solvay and Serum Institute of India Pvt. Ltd.
2.8.1 Solvay and Serum Institute of India Pvt. Ltd. Details
2.8.2 Solvay and Serum Institute of India Pvt. Ltd. Major Business
2.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Product and Services
2.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sementis
2.9.1 Sementis Details
2.9.2 Sementis Major Business
2.9.3 Sementis Pandemic Influenza Vaccine Product and Services
2.9.4 Sementis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pandemic Influenza Vaccine Sales by Manufacturer
3.1 Global Pandemic Influenza Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pandemic Influenza Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Pandemic Influenza Vaccine Manufacturer Market Share
3.4.2 Top 6 Pandemic Influenza Vaccine Manufacturer Market Share
3.5 Global Pandemic Influenza Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pandemic Influenza Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pandemic Influenza Vaccine Market Size by Region
4.1.1 Global Pandemic Influenza Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Pandemic Influenza Vaccine Revenue by Region (2016-2026)
4.2 North America Pandemic Influenza Vaccine Revenue (2016-2026)
4.3 Europe Pandemic Influenza Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Pandemic Influenza Vaccine Revenue (2016-2026)
4.5 South America Pandemic Influenza Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Pandemic Influenza Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pandemic Influenza Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Pandemic Influenza Vaccine Revenue by Type (2016-2026)
5.3 Global Pandemic Influenza Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pandemic Influenza Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Pandemic Influenza Vaccine Revenue by Application (2016-2026)
6.3 Global Pandemic Influenza Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pandemic Influenza Vaccine Sales by Type (2016-2026)
7.2 North America Pandemic Influenza Vaccine Sales by Application (2016-2026)
7.3 North America Pandemic Influenza Vaccine Market Size by Country
7.3.1 North America Pandemic Influenza Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Pandemic Influenza Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pandemic Influenza Vaccine Sales by Type (2016-2026)
8.2 Europe Pandemic Influenza Vaccine Sales by Application (2016-2026)
8.3 Europe Pandemic Influenza Vaccine Market Size by Country
8.3.1 Europe Pandemic Influenza Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Pandemic Influenza Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pandemic Influenza Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Pandemic Influenza Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Pandemic Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Pandemic Influenza Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pandemic Influenza Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pandemic Influenza Vaccine Sales by Type (2016-2026)
10.2 South America Pandemic Influenza Vaccine Sales by Application (2016-2026)
10.3 South America Pandemic Influenza Vaccine Market Size by Country
10.3.1 South America Pandemic Influenza Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Pandemic Influenza Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pandemic Influenza Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Pandemic Influenza Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Pandemic Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Pandemic Influenza Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pandemic Influenza Vaccine Typical Distributors
12.3 Pandemic Influenza Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pandemic Influenza Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pandemic Influenza Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Pandemic Influenza Vaccine Product and Services
Table 6. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Pandemic Influenza Vaccine Product and Services
Table 10. GlaxoSmithKline Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Pandemic Influenza Vaccine Product and Services
Table 14. Novartis Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Pandemic Influenza Vaccine Product and Services
Table 18. Sanofi Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Valneva Basic Information, Manufacturing Base and Competitors
Table 20. Valneva Major Business
Table 21. Valneva Pandemic Influenza Vaccine Product and Services
Table 22. Valneva Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lupin Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Major Business
Table 25. Lupin Pandemic Influenza Vaccine Product and Services
Table 26. Lupin Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Chiron Panacea Basic Information, Manufacturing Base and Competitors
Table 28. Chiron Panacea Major Business
Table 29. Chiron Panacea Pandemic Influenza Vaccine Product and Services
Table 30. Chiron Panacea Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Solvay and Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Solvay and Serum Institute of India Pvt. Ltd. Major Business
Table 33. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Product and Services
Table 34. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sementis Basic Information, Manufacturing Base and Competitors
Table 36. Sementis Major Business
Table 37. Sementis Pandemic Influenza Vaccine Product and Services
Table 38. Sementis Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Pandemic Influenza Vaccine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 40. Global Pandemic Influenza Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Pandemic Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Pandemic Influenza Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 43. Head Office and Pandemic Influenza Vaccine Production Site of Key Manufacturer
Table 44. Global Pandemic Influenza Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 45. Global Pandemic Influenza Vaccine Sales by Region (2021-2026) & (K Doses)
Table 46. Global Pandemic Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Pandemic Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Pandemic Influenza Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 49. Global Pandemic Influenza Vaccine Sales by Type (2021-2026) & (K Doses)
Table 50. Global Pandemic Influenza Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Pandemic Influenza Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Pandemic Influenza Vaccine Price by Type (2016-2021e) & (USD/Dose)
Table 53. Global Pandemic Influenza Vaccine Price by Type (2021-2026) & (USD/Dose)
Table 54. Global Pandemic Influenza Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 55. Global Pandemic Influenza Vaccine Sales by Application (2021-2026) & (K Doses)
Table 56. Global Pandemic Influenza Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Pandemic Influenza Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Pandemic Influenza Vaccine Price by Application (2016-2021e) & (USD/Dose)
Table 59. Global Pandemic Influenza Vaccine Price by Application (2021-2026) & (USD/Dose)
Table 60. North America Pandemic Influenza Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 61. North America Pandemic Influenza Vaccine Sales by Country (2021-2026) & (K Doses)
Table 62. North America Pandemic Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Pandemic Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Pandemic Influenza Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 65. North America Pandemic Influenza Vaccine Sales by Type (2021-2026) & (K Doses)
Table 66. North America Pandemic Influenza Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 67. North America Pandemic Influenza Vaccine Sales by Application (2021-2026) & (K Doses)
Table 68. Europe Pandemic Influenza Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 69. Europe Pandemic Influenza Vaccine Sales by Country (2021-2026) & (K Doses)
Table 70. Europe Pandemic Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Pandemic Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Pandemic Influenza Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 73. Europe Pandemic Influenza Vaccine Sales by Type (2021-2026) & (K Doses)
Table 74. Europe Pandemic Influenza Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 75. Europe Pandemic Influenza Vaccine Sales by Application (2021-2026) & (K Doses)
Table 76. Asia-Pacific Pandemic Influenza Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 77. Asia-Pacific Pandemic Influenza Vaccine Sales by Region (2021-2026) & (K Doses)
Table 78. Asia-Pacific Pandemic Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Pandemic Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Pandemic Influenza Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 81. Asia-Pacific Pandemic Influenza Vaccine Sales by Type (2021-2026) & (K Doses)
Table 82. Asia-Pacific Pandemic Influenza Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 83. Asia-Pacific Pandemic Influenza Vaccine Sales by Application (2021-2026) & (K Doses)
Table 84. South America Pandemic Influenza Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 85. South America Pandemic Influenza Vaccine Sales by Country (2021-2026) & (K Doses)
Table 86. South America Pandemic Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Pandemic Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Pandemic Influenza Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 89. South America Pandemic Influenza Vaccine Sales by Type (2021-2026) & (K Doses)
Table 90. South America Pandemic Influenza Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 91. South America Pandemic Influenza Vaccine Sales by Application (2021-2026) & (K Doses)
Table 92. Middle East & Africa Pandemic Influenza Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 93. Middle East & Africa Pandemic Influenza Vaccine Sales by Country (2021-2026) & (K Doses)
Table 94. Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Pandemic Influenza Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 97. Middle East & Africa Pandemic Influenza Vaccine Sales by Type (2021-2026) & (K Doses)
Table 98. Middle East & Africa Pandemic Influenza Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 99. Middle East & Africa Pandemic Influenza Vaccine Sales by Application (2021-2026) & (K Doses)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Pandemic Influenza Vaccine Typical Distributors
Table 103. Pandemic Influenza Vaccine Typical Customers
List of Figures
Figure 1. Pandemic Influenza Vaccine Picture
Figure 2. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020
Figure 3. Influenza A (H1N1) Vaccines
Figure 4. Other
Figure 5. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2020
Figure 6. Adult
Figure 7. Paediatric
Figure 8. Global Pandemic Influenza Vaccine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 9. Global Pandemic Influenza Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Pandemic Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Pandemic Influenza Vaccine Sales (2016-2026) & (K Doses)
Figure 30. Global Pandemic Influenza Vaccine Production Capacity (2016-2026) & (K Doses)
Figure 31. Global Pandemic Influenza Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Pandemic Influenza Vaccine Market Drivers
Figure 33. Pandemic Influenza Vaccine Market Restraints
Figure 34. Pandemic Influenza Vaccine Market Trends
Figure 35. Global Pandemic Influenza Vaccine Sales Market Share by Manufacturer in 2020
Figure 36. Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturer in 2020
Figure 37. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Pandemic Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Pandemic Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Pandemic Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 41. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2016-2026)
Figure 42. North America Pandemic Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 43. Europe Pandemic Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Pandemic Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. South America Pandemic Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Pandemic Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Global Pandemic Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 48. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2016-2026)
Figure 49. Global Pandemic Influenza Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 50. Global Pandemic Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 51. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2016-2026)
Figure 52. Global Pandemic Influenza Vaccine Price by Application (2016-2026) & (USD/Dose)
Figure 53. North America Pandemic Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 54. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 55. North America Pandemic Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 56. North America Pandemic Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 57. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 58. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 59. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 60. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America Pandemic Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. South America Pandemic Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 68. South America Pandemic Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
新型インフルエンザワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus. Scope of the Re…- 世界のインフルエンザウイルスワクチン（H1N1）市場 2021：企業別、地域別、種類・用途別 The Influenza Virus Vaccine (H1N1) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- インフルエンザ薬・ワクチンの世界市場2018-2025 This study researches the market size of Influenza Drugs and Vaccines, presents the global Influenza Drugs and Vaccines sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of Inf…
- インフルエンザワクチンの世界市場2018-2025 Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, …
- 急速インフルエンザ診断テスト（RIDT）の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Rapid influenza diagnostic tests (RIDTs) are immunoassays which enable the identification of the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. The RIDTs have gained traction over the years owing to the advantages offered by these tests such as quick access to t…